Insulinoma

Current Treatment Options in Oncology

Volumn 4, Issue 4, 2003, Pages 309-317

  Burns, Andrew R ^b   Dackiw, Alan P B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

Distal Pancreatectomy; Hepatic Artery; Hypoglycemia; Insulinoma; Octreotide

Indexed keywords

ARTICLE; HUMAN; INSULINOMA;

HUMANS; INSULINOMA;

EID: 0642366135     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-003-0006-y     Document Type: Article

References (52)

1. Banting FG, Best CH: Internal secretion of the pancreas. J Lab Med 1922, 7:251.
2. Wilder RM, Allan FN, Power MH, et al.: Carcinoma of the islands of the pancreas: hyperinsulinism and hypoglycemia. JAMA 1927, 89:348–355.
3. Howland G, Campbell WR, Maltby EJ, et al.: Dysinsulinism: convulsions and coma due to islet cell tumor of the pancreas with operation and cure. JAMA 1929, 93:674–679.
4. Service FJ, McMahon MM, O’Brien PC, Ballard DJ: Functioning insulinoma: incidence, recurrence and longterm survival of patients: a 60-year study. Mayo Clin Proc 1991, 66:711–719. A long-term institutional experience from a major referral center.
5. Whipple AO, Frantz VK: Adenoma of the islet cell with hyperinsulinism. Ann Surg 1935, 101:1299–1304. DOI: 10.1097/00000658-193506000-00001
6. Service FJ: Hypoglycemic disorders. N Engl J Med 1995, 332:1144–1152. An excellent review on the diagnostic approach to the patient who is hypoglycemic. DOI: 10.1056/NEJM199504273321707
7. Boukhman MP, Karam JM, Shaver J, et al.: Localization of insulinomas. Arch Surg 1999, 134:818–823. A comparison of the insulinoma localization technique. DOI: 10.1001/archsurg.134.8.818
8. Thompson GB: Insulinoma. In Endocrine Surgery. Edited by Prinz RA, Staren ED. Georgetown: Landes Bioscience; 2000:222–228.
9. Hiramoto JS, Feldstein VA, LaBerge JM, Norton JA: Intraoperative ultrasound and preoperative localization detects all occult insulinomas. Arch Surg 2001, 136:1020–1025. DOI: 10.1001/archsurg.136.9.1020
10. Correnti S, Liverani A, Antonini G, et al.: Intraoperative ultrasonography for pancreatic insulinomas. Hepatogastroenterology 1996, 43:207–211.
11. Lo CY, Lam KY, Kung AW, et al.: Pancreatic insulinomas: a 15-year experience. Arch Surg 1997, 132:926–930.
12. Wayne JD, Tanaka R, Kaplan EL: Insulinomas. In Endocrine Surgery. Edited by Clark OH, Duh QY. Philadelphia: WB Saunders Company; 1997:577–591.
13. Saer AJ: Management of hyperinsulinemia with diazoxide in an elderly hemodialysis patient. Nephron 2001, 89:337–339. DOI: 10.1159/000046095
14. Brenthens R, Saltz L: Islet cell tumors of the pancreas: the medical oncologist’s perspective. Surg Clin North Am 2001, 81:527–542. A discussion of the multidisciplinary approach to the patient with insulinoma. DOI: 10.1016/S0039-6109(05)70141-9
15. Boden G: Glucagonomas and insulinomas. Gastroenterol Clin North Am 1989, 18:831–845.
16. Gill GV, Rauf IA, MacFarlane IA: Diazoxide treatment for insulinomas: a national UK survey. Postgrad Med J 1997, 73:640–641. DOI: 10.1136/pgmj.73.864.640
17. Arnold R, Frank M, Kajdan U: Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues. Digestion 1994, 55(Suppl 3):107–113.
18. Saltz L, Trochanowsky B, Buckley M, et al.: Octreotide as an antineoplastic agent in the treatment of functional and non-functional neuro-endocrine tumors. Cancer 1993, 72:244–248. DOI: 10.1002/1097-0142(19930701)72:1<244::AID-CNCR2820720143>3.0.CO;2-Q
19. Moertel CG, Hanley JA, Johnson LA: Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med 1980, 303:1189–1194. DOI: 10.1056/NEJM198011203032101
20. Kvols LK, Buck M: Chemotherapy of endocrine malignancies: a review. Semin Oncol 1987, 14:343–353.
21. Moertel CG, Lefkopoulo M, Lipsitz S, et al.: Streptozocin-doxorubicin, streptozocin-fluorouracil, or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992, 326:519–523. An impotant series showing a survival benefit of chemotherapy in patients with advanced disease. DOI: 10.1056/NEJM199202203260804
22. Rougier P, Mitry E: Chemotherapy in the treatment of neuroendocrine malignant tumors. Digestion 2000, 62(Suppl 1):73–78. DOI: 10.1159/000051859
23. Sridhar KS, Holland JF, Brown JC, et al.: Doxorubicin plus cisplatin in the treatment of apudomas. Cancer 1985, 55:2634–2637. DOI: 10.1002/1097-0142(19850601)55:11<2634::AID-CNCR2820551117>3.0.CO;2-T
24. Marsh RW, Killeen RB Jr: Efficacy of the combination of carboplatin and cyclophosphamide in the treatment of metastatic insulinoma. Cancer Invest 1992, 10:523–524.
25. Ollivier S, Fonck M, Becouarn Y, Brunet R: Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial. Am J Clin Oncol 1998, 21:237–240. DOI: 10.1097/00000421-199806000-00005
26. Moertel CG, Kvols LK, O’Connell MJ, Rubin J: Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Cancer 1991, 68:227–232. DOI: 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I
27. Hesdorffer CS, Stoopler M, Javitch J: Aggressive insulinoma with bone metastases. Am J Clin Oncol 1989, 12:498–501. DOI: 10.1097/00000421-198912000-00008
28. Ulbrecht JS, Schmeltz R, Aarons JH, Greene DA: Insulinoma in a 94-year-old woman: long-term therapy with verapamil. Diabetes Care 1986, 9:186–188. DOI: 10.2337/diacare.9.2.186
29. Hofeldt FD, Dippe SE, Levin SR, et al.: Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma. Diabetes 1973, 23:192–198.
30. Blum I, Doron M, Laron Z, et al.: Prevention of hypoglycemic attacks by propranolol in a patient suffering from insulinoma. Diabetes 1975, 24:535–537. DOI: 10.2337/diabetes.24.6.535
31. Markowitz JC: The hepatic artery. Surg Gynecol Obstet 1953, 95:644–646.
32. Ahlman J, Wangberg B, Jansson S, et al.: Interventional treatment of gastrointestinal neuroendocrine tumours. Digestion 2000, 62(Suppl 1):59–68. DOI: 10.1159/000051857
33. Marlink RG, Lokich JJ, Robins JR, Clouse ME: Hepatic arterial embolization for metastatic hormone-secreting tumors: technique, effectiveness, and complications. Cancer 1990, 65:2227–2232. DOI: 10.1002/1097-0142(19900515)65:10<2227::AID-CNCR2820651011>3.0.CO;2-C
34. Moertel CG, Johnson CM, McKusick MA, et al.: The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994, 120:302–309.
35. Berwaerts J, Verhelst J, Hubens H, et al.: Role of hepatic arterial embolisation in the treatment of metastatic insulinoma: Report of two cases and review of the literature. Acta Clin Belg 1997, 52:263–274.
36. Azimuddin K, Chamberlain RS: The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am 2001, 81:511–525. A review of the surgical approach to neuroendocrine tumors of the pancreas. DOI: 10.1016/S0039-6109(05)70140-7
37. Bliss RD, Carter PB, Lennard TW: Insulinoma: a review of current management. Surg Oncol 1997, 6:49–59. A clear overview of diagnosis and management of insulinoma. DOI: 10.1016/S0960-7404(97)00004-2
38. Sperti C, Pasquali C, Ferronato A, Pedrazzoli S: Median pancreatectomy for tumors of the neck and body of the pancreas. J Am Coll Surg 2000, 190:711–716. DOI: 10.1016/S1072-7515(00)00286-6
39. Evans DB, Lee JE, Pisters PWT, et al.: Periampullary cancer. In Current Surgical Therapy. Edited by Cameron JL. St Louis: Mosby; 2001:558–567.
40. Nakagawa M, Sasakuma F, Kishi Y, Ishikawa O: A successful monitoring for intraoperative calcium stimulation test in complete resection of pancreatic insulinoma. Anesth Analg 2001, 93:239–240. DOI: 10.1097/00000539-200107000-00048
41. Lo CY, van Heerden JA, Thompson GB, et al.: Islet cell carcinoma of the pancreas. World J Surg 1996, 20:878–884. DOI: 10.1007/s002689900134
42. Machado MC, da Cunha JE, Jukemura J, et al.: Insulinoma: diagnostic strategies and surgical treatment. A 22-year experience. Hepatogastroenterology 2001, 48:854–858.
43. Modlin IM, Lewis JJ, Ahlman H, et al.: Management of unresectable malignant endocrine tumors of the pancreas. Surg Gynecol Obstet 1993, 176:507–518.
44. Gagner M, Pomp A, Herrera MF: Early experience with laparoscopic resection of islet cell tumors. Surgery 1996, 120:1051–1054. DOI: 10.1016/S0039-6060(96)80054-7
45. Sussman LA, Christie R, Whittle DE: Laparoscopic excision of distal pancreas including insulinoma. Aust N Z J Surg 1996, 66:414–416.
46. Berends FJ, Cuesta MA, Kazemier G, et al.: Laparoscopic detection and resection of insulinomas. Surgery 2000, 128:386–391. DOI: 10.1067/msy.2000.107413
47. van Nieuwenhove Y, Delvaux G: Laparoscopic management of neuroendocrine tumours of the pancreas. Acta Chir Belg 1999, 99:249–252.
48. Tihanyi TF, Morvay K, Nehez L, et al.: Laparoscopic distal resection of the pancreas with the preservation of the spleen. Acta Chir Hung 1997, 36:359–361.
49. Iihara M, Kanbe M, Okamoto T, et al.: Laparoscopic ultrasonography for resection of insulinomas. Surgery 2001, 130:1086–1091. DOI: 10.1067/msy.2001.118382
50. Anthuber M, Jauch KW, Briegel J, et al.: Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg 1996, 20:73–76. DOI: 10.1007/s002689900013
51. Moscetti L, Saltarelli R, Giuliani R, et al.: Intra-arterial chemotherapy and hormone therapy in malignant insulinoma: case report and review of the literature. Tumori 2000, 86:475–479.
52. Smith CM, Liu J, Chen T, et al.: OctreoTher: ongoing early clinical development of a somatostatin-receptortargeted radionuclide antineoplastic therapy. Digestion 2000, 62(Suppl 1):69–72. DOI: 10.1159/000051858